Synapse - Gastrointestinal Oncology Service

Results (37)

FRONTIER: FAPi Radioligand OpeN-label, phase 1 study to evaluate safety, Tolerability and dosImetry of [Lu-177]-PNT6555; a dose Escalation study for tReatment of patients with select solid tumors

Meeting Abstract

Juneau, D.; Kavan, P.; Metser, U.; Abikhzer, G.; Bodei, L.; Liberman, M.; Taunk, N.; O'Reilly, E. M.; Ma, J. S.; Cioci, R.; more...
Journal of Nuclear Medicine (2024)

Fulltext@MSK | Save

Dose escalation and curative therapy of colorectal cancer with anti-GPA33 self-assembling and disassembling (SADA) actinium-225 alpha pretargeted radioimmunotherapy

Meeting Abstract

Aguirre, N.; Veach, D.; Guo, H. F.; Espinosa-Cotton, M.; Fung, E.; Xu, H.; Feng, Y.; Leung, K.; Cheung, I.; Carrasco, S.; more...
Journal of Nuclear Medicine (2024)

Fulltext@MSK | Save

(18)F-BMS-986229 PET to assess programmed-death ligand 1 status in gastroesophageal cancer

Journal Article

Cytryn, S. L.; Pandit-Taskar, N.; Lumish, M. A.; Maron, S. B.; Gu, P.; Ku, G. Y.; Chou, J. F.; Capanu, M.; Antoine, A.; Loegel, D.; more...
Journal of Nuclear Medicine (2024)

Fulltext@MSK | Save

Sequencing of somatostatin-receptor–based therapies in neuroendocrine tumor patients

Review

Strosberg, J. R.; Al-Toubah, T.; El-Haddad, G.; Lagunes, D. R.; Bodei, L.
Journal of Nuclear Medicine (2024)

Fulltext@MSK | Save

Efficacy of HER2-targeted intraperitoneal (225)Ac α-pretargeted radioimmunotherapy for small-volume ovarian peritoneal carcinomatosis

Journal Article

Chung, S. K.; Vargas, D. B.; Chandler, C. S.; Katugampola, S.; Veach, D. R.; McDevitt, M. R.; Seo, S. H.; Vaughn, B. A.; Rinne, S. S.; Punzalan, B.; more...
Journal of Nuclear Medicine (2023)

Fulltext@MSK | Save

Noninvasive assessment of human epidermal growth factor receptor 2 (HER2) in esophagogastric cancer using (89)Zr-trastuzumab PET: A pilot study

Journal Article

Lumish, M. A.; Maron, S. B.; Paroder, V.; Chou, J. F.; Capanu, M.; Philemond, S.; O'Donoghue, J. A.; Schoder, H.; Lewis, J. S.; Lyashchenko, S. K.; more...
Journal of Nuclear Medicine (2023)

Fulltext@MSK | Save

Interim analysis of a prospective validation of 2 blood-based genomic assessments (PPQ and NETest) to determine the clinical efficacy of (177)Lu-DOTATATE in neuroendocrine tumors

Journal Article

Bodei, L.; Raj, N.; Do, R. K.; Mauguen, A.; Krebs, S.; Reidy-Lagunes, D.; Schöder, H.
Journal of Nuclear Medicine (2023)

Fulltext@MSK | Save

CD8-targeted PET imaging of tumor-infiltrating T cells in patients with cancer: A phase I first-in-humans study of (89)Zr-Df-IAB22M2C, a radiolabeled anti-CD8 minibody

Journal Article

Farwell, M. D.; Gamache, R. F.; Babazada, H.; Hellmann, M. D.; Harding, J. J.; Korn, R.; Mascioni, A.; Le, W.; Wilson, I.; Gordon, M. S.; more...
Journal of Nuclear Medicine (2022)

Fulltext@MSK | Save

Blood based genomic assessment of the clinical efficacy and toxicity of peptide receptor radionuclide therapy (PRRT)

Meeting Abstract

Bodei, L.; Raj, N.; Do, R. K. G.; Krebs, S.; Reidy, D.; Kidd, M.; Drozdov, I.; Modlin, I.; Schoder, H.
Journal of Nuclear Medicine (2021)

Fulltext@MSK | Save

Radioembolization versus bland or chemoembolization for liver-dominant neuroendocrine tumors: Is it an either/or question?

Editorial

Strosberg, J.; El-Haddad, G.; Al-Toubah, T.; Reidy-Lagunes, D.; Ziv, E.; Mahvash, A.; Dasari, A.; Philip, P.; Soulen, M. C.
Journal of Nuclear Medicine (2021)

Fulltext@MSK | Save